Magnus Johnsson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 17, 2026
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months.
Journal: Journal of neurology
Published: January 16, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis.
Journal: European journal of neurology
Published: January 09, 2026
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosis.
Journal: Brain communications
Published: October 02, 2025
Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia.
Journal: Heliyon
Published: December 19, 2022
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 20, 2022
SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder.
Journal: Annals of clinical and translational neurology
Published: February 17, 2022
Cervical myelopathy due to nitrous oxide inhalation
Journal: Lakartidningen
Published: February 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026